Everest Biolabs Unveils Revolutionary EV Research Instruments at ISEV2025 in Vienna
Everest Biolabs, an innovative company in the life sciences sector, has made significant strides in the field of extracellular vesicle (EV) and exosome research. Recently, at the International Society for Extracellular Vesicles (ISEV2025) Annual Meeting held in Vienna, the company launched its new line of products aimed at improving the efficiency and accuracy of EV-related research.
One of the key offerings introduced is the Summit instrument, which is designed specifically for use in biomarker discovery and diagnostic workflows. This advanced device can process up to 48 samples at once, leveraging fully automated EV isolation and concentration techniques within a plate format. The automation minimizes hands-on time, making it suitable for large-scale studies involving extensive patient cohorts or biobanks, all while ensuring standardization essential for clinical applications. This innovative approach not only enhances productivity but also boosts reproducibility in research outcomes.
In addition to the Summit instrument, Everest Biolabs unveiled the Atlas Lumi ELISA Kits. These kits allow for rapid and sensitive quantification as well as purity assessment of EV samples derived from various biofluids. Notably, they feature chemiluminescence assays that demonstrate an industry-leading dynamic range and a high level of sensitivity, required for modern research demands. The kits require minimal sample volumes and streamline the incubation process, ensuring researchers can achieve results efficiently.
George Daaboul, the CEO and co-founder of Everest Biolabs, highlighted the significance of these tools in removing bottlenecks typically associated with EV isolation and analytics. He stated, "Our new products remove bottlenecks in EV isolation and analytics by providing scientists with precise, scalable, and reliable tools. By simplifying and automating complex workflows, we're accelerating discoveries that ultimately translate into impactful clinical applications."
Tal Gilboa, co-founder and the Head of Research at Everest Biolabs, is set to present a poster at the conference that discusses recent findings related to these innovative products. Attendees of ISEV2025 will have the opportunity to engage directly with Everest Biolabs' team at Booth #G5, where live demonstrations of the new products will be showcased, alongside information about early access opportunities for interested researchers.
Founded on the advanced research originating from David Walt's laboratory at the Wyss Institute, Everest Biolabs aims to set a new standard in EV research through a commitment to quality and user-friendly tools. The company is dedicated to fostering innovation while maintaining a 'science first' approach, providing solutions that enhance workflows from the fundamental stages of EV isolation all the way to sophisticated analytics. As they continue to push the boundaries of what's possible in exosome research, Everest Biolabs is poised to make a significant impact on clinical applications related to EVs.
With aspirations to unlock the full potential of EVs in real-world applications, Everest Biolabs remains grounded in its mission, focusing on facilitating vital discoveries through high-quality, accessible research tools. To learn more, you can visit their website at everestbiolabs.com.
One of the key offerings introduced is the Summit instrument, which is designed specifically for use in biomarker discovery and diagnostic workflows. This advanced device can process up to 48 samples at once, leveraging fully automated EV isolation and concentration techniques within a plate format. The automation minimizes hands-on time, making it suitable for large-scale studies involving extensive patient cohorts or biobanks, all while ensuring standardization essential for clinical applications. This innovative approach not only enhances productivity but also boosts reproducibility in research outcomes.
In addition to the Summit instrument, Everest Biolabs unveiled the Atlas Lumi ELISA Kits. These kits allow for rapid and sensitive quantification as well as purity assessment of EV samples derived from various biofluids. Notably, they feature chemiluminescence assays that demonstrate an industry-leading dynamic range and a high level of sensitivity, required for modern research demands. The kits require minimal sample volumes and streamline the incubation process, ensuring researchers can achieve results efficiently.
George Daaboul, the CEO and co-founder of Everest Biolabs, highlighted the significance of these tools in removing bottlenecks typically associated with EV isolation and analytics. He stated, "Our new products remove bottlenecks in EV isolation and analytics by providing scientists with precise, scalable, and reliable tools. By simplifying and automating complex workflows, we're accelerating discoveries that ultimately translate into impactful clinical applications."
Tal Gilboa, co-founder and the Head of Research at Everest Biolabs, is set to present a poster at the conference that discusses recent findings related to these innovative products. Attendees of ISEV2025 will have the opportunity to engage directly with Everest Biolabs' team at Booth #G5, where live demonstrations of the new products will be showcased, alongside information about early access opportunities for interested researchers.
Founded on the advanced research originating from David Walt's laboratory at the Wyss Institute, Everest Biolabs aims to set a new standard in EV research through a commitment to quality and user-friendly tools. The company is dedicated to fostering innovation while maintaining a 'science first' approach, providing solutions that enhance workflows from the fundamental stages of EV isolation all the way to sophisticated analytics. As they continue to push the boundaries of what's possible in exosome research, Everest Biolabs is poised to make a significant impact on clinical applications related to EVs.
With aspirations to unlock the full potential of EVs in real-world applications, Everest Biolabs remains grounded in its mission, focusing on facilitating vital discoveries through high-quality, accessible research tools. To learn more, you can visit their website at everestbiolabs.com.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.